Braskem (BAK) Q2 2026 earnings — TrendMatrix coverage

Reported EPS

$1.62

Estimate

-$3.59

Surprise

+145.2%

Score today

6.0/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Braskem (BAK) beat the -$3.59 estimate with diluted EPS of $1.62 — a large 145.2% upside surprise.

TrendMatrix currently rates BAK Sell at 6.0/10; no pre/post engine snapshot brackets this report.

2 of the last 4 quarters beat the estimate; this quarter's +145.2% surprise compares with a +23.5% four-quarter average. Next scheduled report: 2026-11-12.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$1.87

Price target

$2.76

Stop

$1.80

Upside to target

+47.6%

Reward-to-risk

2.8:1

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.

Industry

Chemicals

Market cap

$773.1M

P/E (fwd)

-1.8

52-week range

$1.40–$5.39

Off 52-week high

65.3%

RSI (14)

50

Volume vs avg

0.68×

Score today

6.0/10